Everything

 

Postmenopausal Osteoporosis Therapeutics – Pipeline Assessment and Market Forecasts to 2017 | PRLog
www.prlog.org | Jul 28, 2011
Postmenopausal Osteoporosis Therapeutics – Pipeline Assessment and Market Forecasts to 2017. Postmenopausal Osteoporosis Therapeutics Market is Forecast to Show Moderate Growth Through 2017 - PR11603379

www.consumerinjurylawyers.com : Fosamax
www.goinglegal.com
Fosamax is Associated With a Rare Femur Fracture:Fosamax is a prescription drug that is a member of the bisphosphonate class of drugs. This drug

Osteoporosis Treatment with ACTONEL
www.actonel.com
ACTONEL prevents and treats osteoporosis. It's the only oral monthly osteoporosis treatment approved to help prevent fractures at both the spine and other areas where fractures commonly occur (other areas were measured as a group, not separately). ACTONEL is clinically proven to help decrease the

Procter & Gamble Backs Drug In Deal to Pay Insurer
www.dddmag.com
Procter & Gamble Co. is betting that its osteoporosis drug will help reduce bone fractures in a new deal with a Midwest insurer.

Medical management following an osteoporotic fracture - EM|consulte
www.em-consulte.com
Orthopaedics & Traumatology: Surgery & Research - Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le jeudi 24 novembre 2011 - Medical management following an osteoporotic fracture - EM|consulte

Comments on 6Minutes.com.au
www.6minutes.com.au | Aug 15, 2007
Home | Contact Us | Advertise | About Us | Privacy Policy | News Archive Medicine Politics Practice Ideas Other stuff Jobs Search Latest Comments Evidence for the efficacy of bisphosponates in prevention of

Integrative Medicine and Wellness
blogs.webmd.com
The Integrative Medicine and Wellness blog has now been retired. We appreciate the wisdom and support Dr. Joseph Pizzorno has brought to the WebMD community throughout the years. If you would like to talk with others about wellness, please join or start a discussion on one of our Health Exchanges.

Amgen Presents Phase 3 Trial Results For Denosumab - Pharmaceutical Business Review
www.pharmaceutical-business-review.com | Sep 21, 2009
Denosumab met all primary and secondary endpoints and demonstrated superior efficacy

Irish Medical Times | Clinical TImes | Osteoporotic vertebral fractures — an overview
www.imt.ie | Jul 22, 2010
<p><em><strong>Rory Hafford</strong> combs the studies for the best management approach to the increasingly common complaint of vertebral fractures</em></p>

What's Bad For Bisphosphonates Is Good For Emisphere - Seeking Alpha
seekingalpha.com | Sep 13, 2011
< strong > By < a href='http://www.eosfunds.com/' > Joseph Ramelli < /a > : < /strong > < p > The FDA convened a special meeting of experts last Friday to discuss safety issues with bisphosphonates. < span > < /span > Bisphosphonates are the multi-billion dollar, dominant class of drugs used for

Results 1-10 of 231
 


Refine by Content Type:



Refine by Source:

31 Sources ...